+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Trivalent ligands for CXCR4 bearing polyproline linkers show specific recognition for cells with increased CXCR4 expression



Trivalent ligands for CXCR4 bearing polyproline linkers show specific recognition for cells with increased CXCR4 expression



Organic and Biomolecular Chemistry 13(32): 8734-8739



The assembly status of G protein-coupled receptors (GPCR) on the cell surface is of interest because the multimerization of GPCR could play pivotal roles in cellular functions. A bivalent ligand with polyproline linkers for CXCR4 has been shown to serve as a "molecular ruler" as a result of the rigid structure of polyproline helices. To expand the utility of the ligands with rigid linkers and explore the possible multimeric forms of GPCR, trivalent ligands with polyproline helices were newly designed and synthesized. The binding affinities of the trivalent ligands for CXCR4 suggested that the ligands recognize the dimeric form of CXCR4 on the cell surface. The fluorescence imaging and analysis by flow cytometry revealed that the ligand with 9 proline linkers binds to CXCR4 with remarkable specificity. The results of the present study suggest that the ligand design with rigid linkers is useful in the multimeric form, but the design of trivalent ligands requires different strategic approaches.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 059175170

Download citation: RISBibTeXText

PMID: 26186480

DOI: 10.1039/c5ob00891c


Related references

Bivalent 14-mer peptide ligands of CXCR4 with polyproline linkers with anti-chemotactic activity against Jurkat cells. Journal of Peptide Science 23(7-8): 574-580, 2017

Bivalent ligands of CXCR4 with rigid linkers for elucidation of the dimerization state in cells. Journal of the American Chemical Society 132(45): 15899-15901, 2011

Increased CXCR4-dependent HIV-1 fusion in activated T cells: role of CD4/CXCR4 association. Journal of Leukocyte Biology 78(6): 1306-1317, 2005

Exploration of labeling by near infrared dyes of the polyproline linker for bivalent-type CXCR4 ligands. Bioorganic and Medicinal Chemistry 23(21): 6967-6973, 2016

Quantitation of CXCR4 mRNA and correlation with CXCR4 cell surface expression on human CD4+ T cells. FASEB Journal 16(4): A153, March 20, 2002

CXCR4 expression in feline mammary carcinoma cells: evidence of a proliferative role for the SDF-1/CXCR4 axis. Bmc Veterinary Research 8: 27, 2012

Down-regulation of CXCR4 expression in MT4 cells by a recombinant vector expressing antisense RNA to CXCR4 and its potential anti-HIV-1 effect. Japanese Journal of Infectious Diseases 57(3): 91-96, 2004

Ex-vivo expansion of migrating human CXCR4+- SCID repopulating cells by upregulation of surface CXCR4 expression in response to stimulation with SCF or IL-6. Blood 92(10 SUPPL 1 PART 1-2): 717A, Nov 15, 1998

Tumor cell-specific blockade of CXCR4/SDF-1 interactions in prostate cancer cells by hTERT promoter induced CXCR4 knockdown: A possible metastasis preventing and minimizing approach. Cancer Biology and Therapy 7(11): 1839-1848, 2008

Expression of chemokine CXCL12 and its receptor CXCR4 in folliculostellate (FS) cells of the rat anterior pituitary gland: the CXCL12/CXCR4 axis induces interconnection of FS cells. Endocrinology 153(4): 1717-1724, 2012

CXCR4 antagonist delivery on decellularized skin scaffold facilitates impaired wound healing in diabetic mice by increasing expression of SDF-1 and enhancing migration of CXCR4-positive cells. Wound Repair and Regeneration 25(4): 652-664, 2017

Regulated expression of CXCR4 constitutive active mutants revealed the up-modulated chemotaxis and up-regulation of genes crucial for CXCR4 mediated homing and engraftment of hematopoietic stem/progenitor cells. Journal of Stem Cells and Regenerative Medicine 9(1): 19-27, 2013

CXCR4 heterogeneous expression in esophageal squamous cell cancer and stronger metastatic potential with CXCR4-positive cancer cells. Diseases of the Esophagus 27(3): 294-302, 2015

Prognostic and predictive value of circulating tumor cells and CXCR4 expression as biomarkers for a CXCR4 peptide antagonist in combination with carboplatin-etoposide in small cell lung cancer: exploratory analysis of a phase II study. Investigational New Drugs 35(3): 334-344, 2017

Widespread CXCR4 activation in astrocytomas revealed by phospho-CXCR4-specific antibodies. Cancer Research 65(24): 11392-9, 2005